KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $77.6 billion.

  • Merck's Total Liabilities rose 639.56% to $77.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $77.6 billion, marking a year-over-year increase of 639.56%. This contributed to the annual value of $100.0 million for FY2024, which is 6000.0% down from last year.
  • Latest data reveals that Merck reported Total Liabilities of $77.6 billion as of Q3 2025, which was up 639.56% from $68.5 billion recorded in Q2 2025.
  • Merck's 5-year Total Liabilities high stood at $77.6 billion for Q3 2025, and its period low was $100.0 million during Q4 2024.
  • Its 5-year average for Total Liabilities is $32.0 billion, with a median of $600.0 million in 2022.
  • In the last 5 years, Merck's Total Liabilities plummeted by 9960.04% in 2023 and then soared by 5327760.0% in 2025.
  • Merck's Total Liabilities (Quarter) stood at $400.0 million in 2021, then skyrocketed by 50.0% to $600.0 million in 2022, then tumbled by 58.33% to $250.0 million in 2023, then tumbled by 60.0% to $100.0 million in 2024, then soared by 77539.0% to $77.6 billion in 2025.
  • Its Total Liabilities stands at $77.6 billion for Q3 2025, versus $68.5 billion for Q2 2025 and $66.7 billion for Q1 2025.